CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −5,500 | 0 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −5,500 | 0 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −5,000 | 5,000 | ||
| 2013-01-23 | Gollust Keith R Director | Option exercise · Director Stock Option (Right to Buy) | −2,250 | 2,250 | ||
| 2012-12-12 | WILSON ROBERT N Director | Grant or award | +58,140 | $8.60 | $500K | 689,679 |
| 2012-12-12 | KUFE DONALD W Director | Grant or award | +5,814 | $8.60 | $50K | 17,748 |
| 2012-12-12 | Kovner Bruce Director | Grant or award | +2,325,581 | $8.60 | $20.0M | 3,273,281 |
| 2012-12-12 | Gollust Keith R Director | Grant or award | +75,000 | $8.60 | $645K | 2,673,383 |
| 2012-12-12 | Gollust Keith R Director | Grant or award | +175,000 | $8.60 | $1.5M | 175,000 |
| 2012-12-12 | Bahcall Safi R President and CEO | Grant or award | +10,000 | $8.60 | $86K | 2,383,135 |
| 2012-11-29 | Singh Amar Sr. VP, Chief Business Officer | Shares withheld for taxes | −3,969 | $8.21 | $33K | 21,031 |
| 2012-11-14 | Kovner Bruce Director | Purchase | +10,500 | $6.95 | $73K | 947,700 |
| 2012-11-12 | Kovner Bruce Director | Purchase | +27,200 | $6.89 | $187K | 937,200 |
| 2012-11-12 | Bahcall Safi R President and CEO | Purchase | +10,000 | $7.12 | $71K | 2,373,135 |
| 2012-09-13 | Rieder Wendy E VP, IP and Legal, Gen. Counsel | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-09-13 | Ehrlich Keith S VP, Fin. and Admin., CFO | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2012-09-13 | Vukovic Vojo SVP, Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 69 of 82 · 1,629 trades